NADAV KIDRON Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NADAV KIDRON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NADAV KIDRON. NADAV KIDRON is a President & CEO in ORAMED PHARMACEUTICALS INC. ($IGVL) and a President and CEO in ORAMED PHARMACEUTICALS INC. ($IGVL).
Address: 2 ELZA STREET JERUSALEM 93706Israel
Companies in which NADAV KIDRON is an Insider
ORAMED PHARMACEUTICALS INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NADAV KIDRON: President and CEO, President & CEO
Holdings: 958,087 shares
Latest Transaction: Feb 08 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of NADAV KIDRON
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 08 2021 | ORMP | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Option Exercise | A | 10.40 | 150,000 | 1,560,000 | 150,000 | |
| Jan 14 2020 | ORMP | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Option Exercise | A | 4.80 | 190,000 | 912,000 | 190,000 | |
| Sep 16 2019 | ORMP | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Option Exercise | A | 3.16 | 196,500 | 620,940 | 196,500 | |
| Sep 16 2019 | ORMP | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Option Exercise | D | 3.16 | 196,500 | 620,940 | 0 | |
| Jul 12 2018 | ORMP | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Buy | P | 5.92 | 122 | 722 | 958,209 | 958.1 K to 958.2 K (+0.01 %) |
| Jul 12 2018 | ORMP | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Sell | S | 5.98 | 61 | 365 | 958,087 | 958.1 K to 958.1 K (-0.01 %) |
| Feb 02 2018 | ORMP | ORAMED PHARMACEUTI ... | KIDRON NADAV | President and CEO | Option Exercise | A | 8.14 | 97,000 | 789,580 | 97,000 |